FY2025 EPS Estimates for OTCMKTS:GTBIF Lowered by Analyst

Green Thumb Industries Inc. (OTCMKTS:GTBIF) – Stock analysts at Alliance Global Partners cut their FY2025 earnings per share estimates for Green Thumb Industries in a research report issued to clients and investors on Thursday, February 27th. Alliance Global Partners analyst A. Grey now anticipates that the company will post earnings per share of $0.17 for the year, down from their previous estimate of $0.19. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share.

Separately, Roth Capital upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research note on Sunday, November 10th. Two analysts have rated the stock with a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Strong Buy” and an average target price of $16.50.

Green Thumb Industries Stock Performance

Shares of OTCMKTS:GTBIF opened at $7.20 on Friday. The firm has a market cap of $1.53 billion, a price-to-earnings ratio of 30.00 and a beta of 1.32. The firm has a fifty day moving average price of $7.36 and a 200 day moving average price of $8.99. Green Thumb Industries has a fifty-two week low of $6.60 and a fifty-two week high of $16.33.

Green Thumb Industries (OTCMKTS:GTBIF) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $294.32 million during the quarter, compared to the consensus estimate of $289.66 million. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.